Dongmei Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Dongmei Wu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Evan Y. Snyder
Department of Pediatrics, University of California at San Diego and Rady Children's Hospital San Diego California
1 shared publicationFang Fang
E.N.T. Department, The First Affiliated Hospital of Jiamusi University, Jiamusi, China
1 shared publicationHaitao Yao
Jiamusi University School of Basic Medical Science
1 shared publication- Jeanne M. Carroll
Department of Pediatrics, University of California, San Diego School of Medicine, San Diego, CA, USA
1 shared publication Jianghua Li
School of Basic Medicine, Jiamusi University, Jiamusi, China
1 shared publication- Jiaqi Song
Department of Physics and Astronomy, University of Waterloo, 200 University Ave. W, Waterloo, ON N2L 3G1, Canada
1 shared publication
Latest Publications
- 14 October 2022
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 280 (2) , 511-517
The gut microbiome and allergic rhinitis; refocusing on the role of probiotics as a treatment option
Introduction In the industrialized world, the incidence of Allergic rhinitis (AR), often known as hay fever, and other allergic disorders continues to grow. Recent studies have suggested environmental variables such as bacterial exposures as a potential reason for the rising prevalence of AR. With breakthroughs in our abilities to research the complex crosstalk of bacteria, the gut microbiomes' effect on human development, nutritional requirements, and immunologic disorders has become apparent Methods Three search engines, including Scopus, Medline, and PubMed, were searched for related published articles up to and including 1st July 2022. Results Several studies have investigated links between commensal microbiome alterations and the development of atopic diseases such as asthma and AR. Besides, studies using probiotics for treating AR suggest that they may alleviate symptoms and improve patient's quality of life. Conclusion Research on probiotics and synbiotics for AR suggests they may improve symptoms, quality of life, and laboratory indicators. A better treatment strategy with advantages for patients may be achieved using probiotics, but only if more detailed in vitro and in vivo investigations are conducted with more participants.
- 14 October 2022
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 280 (2) , 511-517
The gut microbiome and allergic rhinitis; refocusing on the role of probiotics as a treatment option
Introduction In the industrialized world, the incidence of Allergic rhinitis (AR), often known as hay fever, and other allergic disorders continues to grow. Recent studies have suggested environmental variables such as bacterial exposures as a potential reason for the rising prevalence of AR. With breakthroughs in our abilities to research the complex crosstalk of bacteria, the gut microbiomes' effect on human development, nutritional requirements, and immunologic disorders has become apparent Methods Three search engines, including Scopus, Medline, and PubMed, were searched for related published articles up to and including 1st July 2022. Results Several studies have investigated links between commensal microbiome alterations and the development of atopic diseases such as asthma and AR. Besides, studies using probiotics for treating AR suggest that they may alleviate symptoms and improve patient's quality of life. Conclusion Research on probiotics and synbiotics for AR suggests they may improve symptoms, quality of life, and laboratory indicators. A better treatment strategy with advantages for patients may be achieved using probiotics, but only if more detailed in vitro and in vivo investigations are conducted with more participants.
- 16 April 2019
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 30 (5) , 49
Antibacterial properties and biocompatibility in vivo and vitro of composite coating of pure magnesium ultrasonic micro-arc oxidation phytic acid copper loaded
Bone infection and implant secondary removal remains a clinical challenge. We used ultrasonic micro-arc oxidation (UMAO) and conversion of phytic acid copper plating to prepare a pure magnesium polyhydric biofilm; we evaluated the surface microstructures, phase, element composition, and wettability of the film in vitro. The antibacterial activity of films with different Cu contents was confirmed by coating method, imaging examination, and microbiological cultures in vitro. The biocompatibility of biofilms was confirmed by cell proliferation, vitality, and morphology assays in vitro and histological evaluation in vivo. MC3T3-E1 cells were co-cultured with different films to assess cell viability on the films. The results showed that the mass fraction of Cu increased with increasing time of copper plating, and the surface of the Cu group was more dense and uniform. Additionally, copper coating significantly inhibited the growth of E. coli and Staphylococcus aurous. We also found that the adhesion, proliferation, and differentiation of the cells on the surface of copper plating were enhanced. Copper implantation of animals in vivo showed fine ability to promote bone growth. Antibacterial activity and biocompatibility of pure magnesium UMAO-phytic acid-Cu3min implant film are excellent, so the film has potential application value in the treatment of bone implantation.
- 16 April 2019
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 30 (5) , 49
Antibacterial properties and biocompatibility in vivo and vitro of composite coating of pure magnesium ultrasonic micro-arc oxidation phytic acid copper loaded
Bone infection and implant secondary removal remains a clinical challenge. We used ultrasonic micro-arc oxidation (UMAO) and conversion of phytic acid copper plating to prepare a pure magnesium polyhydric biofilm; we evaluated the surface microstructures, phase, element composition, and wettability of the film in vitro. The antibacterial activity of films with different Cu contents was confirmed by coating method, imaging examination, and microbiological cultures in vitro. The biocompatibility of biofilms was confirmed by cell proliferation, vitality, and morphology assays in vitro and histological evaluation in vivo. MC3T3-E1 cells were co-cultured with different films to assess cell viability on the films. The results showed that the mass fraction of Cu increased with increasing time of copper plating, and the surface of the Cu group was more dense and uniform. Additionally, copper coating significantly inhibited the growth of E. coli and Staphylococcus aurous. We also found that the adhesion, proliferation, and differentiation of the cells on the surface of copper plating were enhanced. Copper implantation of animals in vivo showed fine ability to promote bone growth. Antibacterial activity and biocompatibility of pure magnesium UMAO-phytic acid-Cu3min implant film are excellent, so the film has potential application value in the treatment of bone implantation.
- 16 May 2014
- Published by Wiley in Current Protocols in Stem Cell Biology
- Vol. 29 (1) , 1C.16.1-1C.16.13
Generation, Expansion, and Differentiation of Human Induced Pluripotent Stem Cells (hiPSCs) Derived From the Umbilical Cords of Newborns
The umbilical cord is tissue that is normally discarded after the delivery of the infant, but it has been shown to be a rich source of stem cells from the cord blood, Wharton's jelly, and umbilical endothelial cells. Patient‐specific human induced pluripotent stem cells (hiPSCs) reprogrammed from patient specific human umbilical vein endothelial cells in the neonatal intensive care unit (NICU) population (specifically, premature neonates) have not been shown in the literature. This unit describes a protocol for the generation and expansion of hiPSCs originating from umbilical cords collected from patients in the NICU. Curr. Protoc. Stem Cell Biol. 29:1C.16.1‐1C.16.13. © 2014 by John Wiley & Sons, Inc. Keywords: umbilical cord; HUVEC; reprogramming; iPS
- 16 May 2014
- Published by Wiley in Current Protocols in Stem Cell Biology
- Vol. 29 (1) , 1C.16.1-1C.16.13
Generation, Expansion, and Differentiation of Human Induced Pluripotent Stem Cells (hiPSCs) Derived From the Umbilical Cords of Newborns
The umbilical cord is tissue that is normally discarded after the delivery of the infant, but it has been shown to be a rich source of stem cells from the cord blood, Wharton's jelly, and umbilical endothelial cells. Patient‐specific human induced pluripotent stem cells (hiPSCs) reprogrammed from patient specific human umbilical vein endothelial cells in the neonatal intensive care unit (NICU) population (specifically, premature neonates) have not been shown in the literature. This unit describes a protocol for the generation and expansion of hiPSCs originating from umbilical cords collected from patients in the NICU. Curr. Protoc. Stem Cell Biol. 29:1C.16.1‐1C.16.13. © 2014 by John Wiley & Sons, Inc. Keywords: umbilical cord; HUVEC; reprogramming; iPS